Home · Briefings

Briefing 03 · Design · 4 min read

Placebos and blinding, without the mystery

Words like “double-blind” make research sound secretive. In practice they are fairness tools, and the consent process has to explain them to you.

Key takeaways

  • A placebo is a look-alike with no active ingredient. It is not used when it would be unsafe to withhold proven treatment.
  • Randomization assigns groups by chance so comparisons are fair.
  • In a blinded study you are not told your group until the end, but the team can find out in an emergency.

What a placebo is, and is not

A placebo looks like the study treatment but has no active ingredient. Comparing it with the real thing helps researchers separate the effect of the treatment from the effect of simply expecting to feel better, which is real and can be strong.

Many studies do not use a placebo at all. When there is already an effective treatment, the comparison is usually between the new option and the current standard.

Randomization

If people choose their own group, the groups may differ in ways that bias the result. Randomization hands out assignments by chance, like drawing lots, so those differences spread out evenly. You will usually be told your odds, such as one in two.

Blinding

In a single-blind study you do not know your group. In a double-blind study neither you nor the staff giving the treatment know. This keeps expectations from nudging the results. If a medical emergency makes it important to know, the study has a way to unblind quickly.

What the consent form must tell you

  • Whether a placebo or other comparison is used
  • Your chance of being in each group
  • Whether and when you will be told your group at the end
  • What alternatives you have outside the study

General information only. This briefing is not medical, legal, or financial advice, and Trialuma is not a medical provider. Talk with your own doctor about your health.

Next step

Keep the briefings close.

Tell us what you’d like to read about. It’s free, there’s no obligation, and you can opt out of texts any time by replying STOP.

Get the briefings